Home › Funds › Liontrust Investment Partners LLP › EW
Liontrust Investment Partners LLP position in EW
EDWARDS LIFESCIENCES CORP · Health Care
Liontrust Investment Partners LLP reported holding 1,216,379 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q2 2026 13F filing — a position valued at US$110.0M, representing 1.62% of its reported portfolio and ranking #21 among its reported holdings. Liontrust Investment Partners LLP has disclosed EW holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Liontrust Investment Partners LLP's EW position evolved
Liontrust Investment Partners LLP first disclosed a stake in EW in Q3 2023 at 18,650 shares (US$1.3M). The position peaked in Q4 2024 at 1,610,439 shares, worth US$119.2M. Across 12 filings, Liontrust Investment Partners LLP increased the stake 3 time(s), trimmed it 7 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 1,216,379 shares valued at US$110.0M — an increase of 78,008 shares quarter over quarter.. Notable position changes include a 6746% increase in Q4 2023 (shares rose 25% over the following quarter), a 33% increase in Q4 2024 (shares fell 2% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 18.65K | $1.29M | New |
| Q4 2023 | 1.28M | $97.35M | Add |
| Q1 2024 | 1.24M | $118.03M | Reduce |
| Q2 2024 | 1.21M | $111.60M | Reduce |
| Q3 2024 | 1.21M | $111.60M | Hold |
| Q4 2024 | 1.61M | $119.22M | Add |
| Q1 2025 | 1.52M | $110.04M | Reduce |
| Q2 2025 | 1.43M | $112.04M | Reduce |
| Q3 2025 | 1.36M | $105.78M | Reduce |
| Q4 2025 | 1.24M | $106.08M | Reduce |
| Q1 2026 | 1.14M | $91.16M | Reduce |
| Q2 2026 | 1.22M | $110.03M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EW and 13F data
EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 34 other funds we track also report a position in EW — the largest reported positions include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$1.18B), Ninety One UK Ltd (US$1.03B), Aristotle Capital Management, LLC (US$783.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EW
- DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt 13.00M sh · $1.18B · Q2 2026
- Ninety One UK Ltd 11.94M sh · $1.03B · Q3 2026
- Aristotle Capital Management, LLC 8.67M sh · $783.91M · Q2 2026
- BROWN ADVISORY INC 7.37M sh · $666.33M · Q2 2026
- Artisan Partners Limited Partnership 6.63M sh · $599.36M · Q2 2026
- WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST 4.80M sh · $434.21M · Q2 2026
More on Liontrust Investment Partners LLP
FAQ
How long has Liontrust Investment Partners LLP held EW?
Liontrust Investment Partners LLP has disclosed EW holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Liontrust Investment Partners LLP's current position in EW?
As of Q2 2026, Liontrust Investment Partners LLP holds 1.22M shares of EW (EDWARDS LIFESCIENCES CORP), valued at $110.03M, representing 1.62% of its reported portfolio and ranking #21.
Has Liontrust Investment Partners LLP been buying or selling EW?
In the latest 13F filing (Q2 2026), Liontrust Investment Partners LLP increased its position in EW. The position peaked in Q4 2024 at 1.61M shares.
Which other funds hold EW?
Other major institutional holders of EW include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, Ninety One UK Ltd, Aristotle Capital Management, LLC, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.